Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KRP-116D Phase I Pharmacokinetic Study in Healthy Japanese Males
jRCT2080223886Phase 1Completed
- Sponsor
- Kyorin Pharmaceutical
- Start
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of Dimethyl sulfoxide in urogenital disease, sponsored by Kyorin Pharmaceutical. Primary endpoints: Pharmacokinetics of KRP-116D and Adverse events. Started Apr 2018; status: completed.
02
Drugs
Dimethyl sulfoxide
03
Conditions
urogenital disease
Beyond the preview
Go deeper on jRCT2080223886.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223886.